Skip to main content
. Author manuscript; available in PMC: 2016 Feb 23.
Published in final edited form as: Stroke. 2014 Jul 3;45(8):2366–2371. doi: 10.1161/STROKEAHA.114.005145

Table 1.

General characteristics of the study population, by cohort.

Tromsø MDCS CAPS CHS Total
No. of participants 6659 6103 5056 5888 23706
Age (years) 60.2 ± 10.2 57.5 ± 5.9 50.1 ± 13.1 72.8§ ± 5.6 60.5 ± 12.1
Male sex 3298 (49.5%) 2572 (42.1%) 2471 (48.9%) 2495 (42.4%) 10836 (45.7%)
History of vascular disease 954 (14.3%) 167 (2.7%) 155 (3.1%) 2213 (37.6%) 3489 (14.7%)
  Coronary heart disease 825 (12.4%) 102 (1.7%) 108 (2.1%) 1997 (33.9%) 3032 (12.8%)
  Stroke 182 (2.7%) 69 (1.1%) 52 (1.0%) 349 (5.9%) 652 (2.8%)
Body mass index (kg/m2) 26.1 ± 4.0 25.9 ± 4.0 26.6 ± 4.1 26.7 ± 4.7 26.3 ± 4.2
Waist-hip ratio 0.87 ± 0.08 0.85 ± 0.09 0.95 ± 0.11 0.93 ± 0.09 0.90 ± 0.10
Hypertension* 4006 (60.2%) 3891 (63.8%) 1320 (26.1%) 3681 (62.5%) 12898 (54.4%)
  Systolic blood pressure (mmHg) 145 ± 23 141 ± 19 128 ± 17 137 ± 22 138 ± 21
  Diastolic blood pressure (mmHg) 83 ± 13 87 ± 9 77 ± 10 71 ± 11 80 ± 13
Diabetes mellitus 217 (3.3%) 277 (4.5%) 134 (2.7%) 722 (12.3%) 1350 (5.7%)
Current smoking 2118 (31.8%) 1724 (28.2%) 1057 (20.9%) 700 (11.9%) 5599 (23.6%)
Hyperlipidemia 2518 (37.8%) 2447 (40.1%) 720 (14.2%) 1563 (26.5%) 7248 (30.6%)
  TC/HDL ratio 4.7 ± 1.6 4.8 ± 1.5 3.8 ± 1.1 4.2 ± 1.3 4.4 ± 1.4
Moderate stenosis
  Observed prevalence 1.8% 0.6% 0.8% 4.4% 2.0%
  Expected prevalence# 1.9% 1.3% 2.6% 2.1% 2.0%
Severe stenosis
  Observed prevalence 0.7% 0.1% 0.2% 1.1% 0.5%
  Expected prevalence# 0.8% 0.3% 0.8% 0.5% 0.5%
*

Hypertension is defined as a systolic blood pressure above 140mmHg or an diastolic blood pressure above 90mmHg.

Diabetes mellitus is defined as a glucose level above 6.9mmol/l or anti diabetic medicine use.

Hyperlipidemia defined as an TC/HDL ratio above 5mmol/l or statin use.

§

inclusion criteria: age 65 and older.

classification method: peak systolic velocity ratio method (Tromso), lumen diameter reduction (MDCS), cross sectional area reduction method (CAPS), peak systolic velocity (CHS).

#

given the risk factor distribution of the total study population.